Anthem Biosciences Limited
Societe Generale bought 3,35,661 shares of Anthem Biosciences Limited for ₹25.00 Cr at ₹744.80 apiece in a block deal. A total of 1.71 crore shares, representing a 3.05% stake, were sold by promoter Aruna Ganesh in the block deal for ₹1,275 crore.
A biotechnology company providing contract research, development, and manufacturing services alongside specialty ingredients production. Established in 2006, the company serves pharmaceutical and nutraceutical sectors through its integrated CRDMO capabilities and custom synthesis expertise. Its distinctive position lies in combining comprehensive development expertise with in-house manufacturing facilities, enabling end-to-end solutions for clients requiring specialized ingredient formulation, process optimization, and commercial-scale production services.
French global investment bank with around EUR 1.6 trillion in assets. India FPI activity covers proprietary, market-making and client flows in listed Indian equities.